Managing Compliance during the Pandemic Recorded Webinar | Danielle DeLucy | From: Jan 15, 2021 - To: Dec 31, 2021 |
Understand how the COVID-19 pandemic can affect manufacturing operations, employee safety, and how to be flexible and creative in these uncertain times when it comes to business continuity.
Learning Objectives:-
Webinar Takeaways:-
Background – How did this become a pandemic?
Employee Engagement / Interaction
Impact on IT systems
Facilities
Impact on Workforce
Supply Chain / Distribution
Why Should You Attend:-
The pharmaceutical world is mostly staying the course during the unprecedented conditions of the world as we are all living through the COVID-19 pandemic, but that doesn’t mean there aren’t measures that can be taken to make the workplace environment to continue to operate seamlessly and most importantly safely. This course will help attendees understand how the COVID-19 pandemic can affect manufacturing operations. You can ensure employee safety and be flexible and creative despite these uncertain times when it comes to business continuity. Learn how.
Who Will Benefit?
This 60-minute session is intended for professionals in the Medical Device, Biotechnology, Pharmaceutical Industry. Although not presently stated in the draft, the same guide could be used by FDA Regulated Industries personnel
Danielle DeLucy
Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance.
Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations.
Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she has held positions in the Quality management arena while increasing her responsibility. She has helped to lead many Regulatory Health Inspections and was instrumental in the coaching process of her peers prior to any inspection.
Currently, Danielle assists companies who are faced with warning letters, consent decrees and those wishing to improve compliance establish more robust quality systems so that the company can succeed.